Lincocin 300 mg contains Clindamycin, a lincosamide antibiotic used to treat a wide range of bacterial infections caused by susceptible gram-positive and anaerobic bacteria. It is effective in both mild and severe infections, including those affecting the respiratory tract, skin, bones, joints, pelvis, and abdomen. Additionally, Lincocin 300 mg can be used as an alternative therapy in combination with quinine or amodiaquine for the treatment of multi-drug resistant Plasmodium falciparum infections.

Clindamycin works by inhibiting bacterial protein synthesis, preventing bacterial growth and multiplication. This makes Lincocin a reliable choice for treating infections when penicillin is contraindicated or ineffective.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Macrolides / Lincosamide Antibiotic

Indications

Lincocin 300 mg is indicated for the treatment of infections caused by susceptible strains of bacteria, including Streptococci, Staphylococci, Pneumococci, and anaerobic species such as Bacteroides, Fusobacterium, Propionibacterium, Eubacterium, Actinomyces, and Peptostreptococcus.

Specific infections include:

• Upper and lower respiratory tract infections – sinusitis, bronchitis, pneumonia

• Skin and soft tissue infections – abscesses, cellulitis, wound infections

• Bone and joint infections – osteomyelitis, septic arthritis

• Pelvic and intra-abdominal infections – pelvic inflammatory disease, peritonitis

• Septicemia and endocarditis

• Dental infections – abscesses, gingivitis

• Alternative therapy for malaria – in combination with quinine or amodiaquine for multi-drug resistant Plasmodium falciparum

It is suitable for use in adults, children, and neonates with appropriate dosing and monitoring.

Pharmacology

Clindamycin inhibits bacterial protein synthesis by binding to the 50S subunit of bacterial ribosomes. It is bacteriostatic at low concentrations and bactericidal at higher concentrations. Clindamycin is active against:

• Aerobic gram-positive cocci: Staphylococcus aureus, Staphylococcus epidermidis, Streptococci, Pneumococci

• Anaerobic gram-negative bacilli: Bacteroides spp., Fusobacterium spp.

• Anaerobic gram-positive bacilli: Propionibacterium, Eubacterium, Actinomyces, Peptostreptococcus, C. perfringens

It penetrates well into most tissues and body fluids except the cerebrospinal fluid and is metabolized by the liver with partial excretion via bile and urine.

Dosage and Administration

Oral administration (capsule/suspension):

• Adults:

  • Serious infections: 150–300 mg every 6 hours

  • Severe infections: 300–450 mg every 6 hours

• Children:

  • Serious infections: 8–16 mg/kg/day divided into 3–4 doses

  • Severe infections: 16–20 mg/kg/day divided into 3–4 doses

Parenteral administration (IM/IV):

• Adults: 600–1200 mg/day in 2–4 doses for serious infections; 1200–2700 mg/day for severe infections

• Pediatric patients (1 month–16 years): 20–40 mg/kg/day in 3–4 doses

Note: Therapy may be transitioned from IV/IM to oral capsules when the patient’s condition allows. For hemolytic streptococcal infections, treatment should continue for at least 10 days.

Precautions

• Use with caution in patients with a history of gastrointestinal disease, especially colitis

• May enhance the action of other neuromuscular blocking agents

• Avoid concurrent administration with erythromycin due to antagonistic effects

• Monitor organ function in newborns and infants

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Hypersensitivity to Clindamycin, lincomycin, or any ingredient of the formulation

• Previous history of antibiotic-associated colitis

Side Effects

• Gastrointestinal: abdominal pain, nausea, vomiting, diarrhea

• Esophageal irritation or ulceration

• Skin reactions: rash, pruritus, urticaria

Pregnancy & Lactation

• Pregnancy Category B: Clindamycin crosses the placenta and should be used only if clearly needed

• Appears in breast milk; avoid in nursing mothers unless necessary

Overdose

• Symptoms similar to normal dose side effects

• Haemodialysis and peritoneal dialysis are ineffective in removing Clindamycin

• Treat with gastric lavage if needed; no specific antidote

Storage

Store in a dry place, away from light and heat. Keep out of reach of children.